BioInsights - Accelerating immuno-oncology innovation using humanized mouse models
Sep
21
2022
On demand

Accelerating immuno-oncology innovation using humanized mouse models

Sponsor
Accelerating immuno-oncology innovation using humanized mouse models

Join us for this very exciting webinar where we discuss some of the most valuable immunology and oncology research tools available to date: humanized mouse models. Learn how these robust, translationally relevant mouse models are rapidly changing preclinical drug development in ways we never thought possible.

  • Humanized components of the immune/oncology checkpoint pathways
  • Models for bi-specific antibody development
  • Next generation immunodeficient mice (NCG) for xenografts and better stem cell engraftment

Santi Suryani Chen PhD

Associate Director of Immuno-Oncology, GemPharmatech

Santi is a research scientist and business development professional with over 10 years of experience in autoimmune disease, immunology, and oncology disease areas. Santi received her training in human B cell development at the Garvan Institute of Medical Research Australia in Immunology, followed by a postdoctoral fellowship at the Children’s Cancer Institute Australia, focusing on pediatric leukemia and therapies. Her projects include testing agents' efficacy and mechanisms such as navitoclax, venetoclax, and selumetinib. Her research projects resulted in multiple publications in journals such as Blood and Journal of Immunology and national/international awards.

SPEAKERS

Santi Chen
Santi Chen
Associate Director of Immuno-Oncology, GemPharmatech